It describes lipids containing Tao peptide (preferably Tao PO 4) and complexes containing Tao peptide (preferably Tao PO 4) that bind to an immune carrier. It also describes the drug composition and the use of fat and / or polymers to treat or prevent neurodegenerative diseases or disorders,It's like Alzheimer's 11. Claim 10: the pharmaceutical composition containing the lipid of any one of the claims 1-9 and an acceptable pharmaceutical vehicle. Claim 11: a modification consisting of phosphorous pottery and an immune carrier bound through a can, wherein the modification has the structure of (I) formula (1) or (II) formula (2), where X represents integers 0 to 10, preferably 2 to 6, preferably 3； and 3 to 15, preferably 3 to 12 Claim 12: combined with claim 11,There, vaccination vehicles were selected from the hemophilia group in LHL, California,Tetanus toxin, CRM197 and N. meningitis (OMP) outer membrane protein mixture,Or their derivatives Claim 17: a method of immune response to a patient with neurodegenerative disorder, including the control of the pharmaceutical ingredients of claim 10 or requirement 16. 115. Claim 22: a kit comprising at least one of the pharmaceutical components of claim 10 and the pharmaceutical component of claim 16 for the treatment or prevention of a neurodegenerative disease or disorder as required.Se describen liposomas que contienen péptidos tau, preferiblemente péptidos tau fosforilados, y conjugados que contienen péptidos tau, preferiblemente péptidos tau fosforilados, conjugados a un vehículo inmunogénico. También se describen composiciones farmacéuticas y usos de los liposomas y/o conjugados para tratar o prevenir una enfermedad o trastorno neurodegenerativo, tal como la enfermedad de Alzheimer. Reivindicación 10: Una composición farmacéutica que comprende el liposoma de una cualquiera de las reivindicaciones 1 - 9 y un vehículo farmacéuticamente aceptable. Reivindicación 11: Un conjugado que comprende un fosfopéptido tau y un vehí
